Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 1998
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 1998
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2001
CompletedFirst Submitted
Initial submission to the registry
July 3, 2001
CompletedFirst Posted
Study publicly available on registry
July 5, 2001
CompletedJanuary 21, 2009
December 1, 2004
July 3, 2001
January 20, 2009
Conditions
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
VA Puget Sound Health Care System
Lakewood, Washington, 98493-5000, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
Suzanne Craft, Ph.D
Laura Baker, Ph.D
Murray Raskind, M.D.
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
Study Record Dates
First Submitted
July 3, 2001
First Posted
July 5, 2001
Study Start
April 1, 1998
Study Completion
March 1, 2001
Last Updated
January 21, 2009
Record last verified: 2004-12